Published in Ann Anesthesiol Fr on January 01, 1978
Diagnostic score for heparin-induced thrombocytopenia after cardiopulmonary bypass. J Thromb Haemost (2004) 1.79
Geographic distribution of the 20210 G to A prothrombin variant. Thromb Haemost (1998) 1.71
Percutaneous transluminal angioplasty for emboligenic arterial lesions after radiotherapy of axillary arteries. J Vasc Surg (1995) 1.49
Thrombomodulin prolongs thrombin-induced extracellular signal-regulated kinase phosphorylation and nuclear retention in endothelial cells. Circ Res (2001) 1.49
Thromboangiitis obliterans (Buerger's disease). Rev Rhum Engl Ed (1997) 1.41
Antiphospholipid antibodies and atherosclerosis. Am J Med (1992) 1.41
Rheumatic manifestations in patients with thromboangiitis obliterans (Buerger's disease). J Rheumatol (1999) 1.40
[Rapid selection that rectifies a diagnosis of arteritis!]. Presse Med (2000) 1.39
Infected infrarenal aortic aneurysms: when is in situ reconstruction safe? J Vasc Surg (1993) 1.34
Unexplained thrombosis and factor V Leiden mutation. Lancet (1994) 1.28
Breast milk jaundice: in vitro inhibition of rat liver bilirubin-uridine diphosphate glucuronyltransferase activity and Z protein-bromosulfophthalein binding by human breast milk. Pediatr Res (1976) 1.22
Effects of oral and transdermal estrogen/progesterone regimens on blood coagulation and fibrinolysis in postmenopausal women. A randomized controlled trial. Arterioscler Thromb Vasc Biol (1997) 1.21
Femoropopliteal stent placement: long-term results. Radiology (1992) 1.11
Atheroembolism in HIV-positive individuals. Lancet (1992) 1.09
Factors V leiden and II 20210A in patients with symptomatic pulmonary embolism and deep vein thrombosis. Am J Med (2001) 1.07
Hypothenar hammer syndrome: seventeen cases with long-term follow-up. J Vasc Surg (1987) 1.04
Possible autoimmune processes related to chromosomal abnormalities (breakage) in NZB mice. Nat New Biol (1972) 1.01
Hypercoagulable states in primary upper-extremity deep vein thrombosis. Arch Intern Med (2000) 1.01
Met 358 to Arg mutation of alpha 1-antitrypsin associated with protein C deficiency in a patient with mild bleeding tendency. J Clin Invest (1992) 1.00
Complex association of protein C gene promoter polymorphism with circulating protein C levels and thrombotic risk. Arterioscler Thromb Vasc Biol (1999) 1.00
The factor II G20210A gene polymorphism, but not factor V Arg506Gln, is associated with peripheral arterial disease: results of a case-control study. J Thromb Haemost (2004) 1.00
Embolization of hypogastric artery aneurysm: 17 cases. Ann Vasc Surg (2001) 1.00
[French medical periodicals in the international scene?]. Bull Acad Natl Med (1989) 0.98
Comparison of a once daily with a twice daily subcutaneous low molecular weight heparin regimen in the treatment of deep vein thrombosis. FRAXODI group. Thromb Haemost (1998) 0.98
Vertebral arteriovenous fistulas: a study of 49 cases and review of the literature. Cardiovasc Surg (1994) 0.98
Arterial thrombosis: a rare complication of the nephrotic syndrome. Cardiovasc Surg (1993) 0.97
Adjusted versus fixed doses of the low-molecular-weight heparin fragmin in the treatment of deep vein thrombosis. Fragmin-Study Group. Thromb Haemost (1994) 0.95
Polymorphisms in the 5' regulatory region of the tissue factor gene and the risk of myocardial infarction and venous thromboembolism: the ECTIM and PATHROS studies. Etude Cas-Témoins de l'Infarctus du Myocarde. Paris Thrombosis case-control Study. Arterioscler Thromb Vasc Biol (2000) 0.95
Breakage factor in systemic sclerosis and protector effect of L-cysteine. Humangenetik (1974) 0.95
Congenital anomalies of the external iliac artery: case report and review of the literature. Ann Vasc Surg (1990) 0.94
[Spontaneous pneumoperitoneum in scleroderma]. Gastroenterol Clin Biol (1984) 0.93
Oral Beraprost sodium, a prostaglandin I(2) analogue, for intermittent claudication: a double-blind, randomized, multicenter controlled trial. Beraprost et Claudication Intermittente (BERCI) Research Group. Circulation (2000) 0.92
Antithrombin III mutation database: first update. For the Thrombin and its Inhibitors Subcommittee of the Scientific and Standardization Committee of the International Society on Thrombosis and Haemostasis. Thromb Haemost (1993) 0.92
Demonstration of an association between Chlamydia pneumoniae infection and venous thromboembolic disease. Thromb Haemost (2000) 0.92
Activation-induced exposure of the thrombin anion-binding exosite. Interactions of recombinant mutant prothrombins with thrombomodulin and a thrombin exosite-specific antibody. J Biol Chem (1994) 0.92
Protein S deficiency: a database of mutations--summary of the first update. Thromb Haemost (2000) 0.92
Follow-up electron beam CT for the management of early phase Takayasu arteritis. J Comput Assist Tomogr (2001) 0.92
Endovascular treatment of iliac aneurysms with covered stents. Ann Vasc Surg (2000) 0.91
[Erasmus syndrome in a dental technician. Importance of the prevention of occupational hazards]. Ann Med Interne (Paris) (1983) 0.91
Protein S deficiency. Thromb Haemost (1997) 0.91
The angiopoietin pathway is modulated by PAR-1 activation on human endothelial progenitor cells. J Thromb Haemost (2006) 0.91
Does karate injure blood vessels of the hand? Lancet (1984) 0.91
Endothelial progenitor cells: characterization, in vitro expansion, and prospects for autologous cell therapy. Cell Biol Toxicol (2007) 0.91
Nailfold capillary microscopy in mixed connective tissue disease. Comparison with systemic sclerosis and systemic lupus erythematosus. Arthritis Rheum (1986) 0.91
Bilirubin UDP-glucuronyltransferase activity of wistar rat kidney. Am J Physiol (1975) 0.90
[Chromosome anomalies in generalized scleroderma. A study of 6 patients]. C R Acad Sci Hebd Seances Acad Sci D (1969) 0.90
[Acquired dysfibrinogenemia and hepatic disorders. Apropos of 30 cases]. Sem Hop (1973) 0.90
Proximal arterial dilatation developing after surgical closure of long-standing posttraumatic arteriovenous fistula. Ann Vasc Surg (1997) 0.90
[Idiopathic and secondary Raynaud's phenomenon. A comparative psychosomatic approach]. Presse Med (1990) 0.89
[Relationship between digital necrosis of the upper limbs and malignant conditions (author's transl)]. Nouv Presse Med (1978) 0.89
Platelet microparticle levels: a biomarker of thromboangiitis obliterans (Buerger's disease) exacerbation. J Cell Mol Med (2009) 0.89
Systemic sclerosis and cryoglobulinemia. Clin Immunol Immunopathol (1976) 0.89
High levels of portal TNF-alpha during abdominal aortic surgery in man. Cytokine (1993) 0.89
Percutaneous iliac artery stent: angiographic long-term follow-up. Radiology (1991) 0.88
Influence of surgery on in-vitro cytokine production by human monocytes. Cytokine (1992) 0.87
Venous thromboembolic disease and the prothrombin, methylene tetrahydrofolate reductase and factor V genes. Thromb Haemost (1999) 0.87
Role of the P2Y12 gene polymorphism in platelet responsiveness to clopidogrel in healthy subjects. J Thromb Haemost (2006) 0.87
Fine structural capillary changes and basal lamina thickening in scleroderma (progressive systemic sclerosis) and Raynaud's disease. Pathol Res Pract (1984) 0.87
[Raynaud's phenomenone: prospective study of 100 cases (author's transl)]. Nouv Presse Med (1979) 0.87
Mechanism of protein C deficiency in a patient with arginine 358 alpha 1-antitrypsin (Pittsburgh mutation): role in the maintenance of hemostatic balance. J Lab Clin Med (1995) 0.86
Interdonor variability of platelet response to thrombin receptor activation: influence of PlA2 polymorphism. Br J Haematol (1997) 0.86
Molecular basis for protein S hereditary deficiency: genetic defects observed in 118 patients with type I and type IIa deficiencies. The French Network on Molecular Abnormalities Responsible for Protein C and Protein S Deficiencies. J Lab Clin Med (1996) 0.86
Antithrombin III and heparin cofactor II in patients with chronic renal failure undergoing regular hemodialysis. Thromb Haemost (1987) 0.86
Myocardial infarction, Arg 506 to Gln factor V mutation, and activated protein C resistance. Lancet (1995) 0.86
[Medical treatment of aortic aneurysms using beta-blockers]. J Mal Vasc (1995) 0.85
Should thromboprophylactic dosage of low molecular weight heparin be adapted to patient's weight? Thromb Haemost (1988) 0.85
Critical ischemia during heparin-induced thrombocytopenia. Treatment by intra-arterial streptokinase. Thromb Res (1984) 0.85
Long-term follow-up of positive cultures in 500 abdominal aortic aneurysms. Arch Surg (1993) 0.85
Renal revascularization in high-risk patients: the role of iliac renal bypass. Ann Vasc Surg (1992) 0.85
[A new biological test for cholostasis]. Presse Med (1965) 0.85
[Cutaneous lymphangioma. Value of the scanner. Pathogenic hypothesis and therapeutic implications]. J Mal Vasc (1984) 0.84
Endothelial cell renewal in skin of patients with progressive systemic sclerosis (PSS): an in vitro autoradiographic study. Acta Derm Venereol (1982) 0.84